We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
-2.66%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$344M
AUM Growth
-$21.8M
(-5.9%)
Cap. Flow
-$6.55M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
27.91%
Holding
117
New
5
Increased
25
Reduced
42
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.19M |
| 2 |
Amazon
AMZN
|
+$1.04M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$699K |
| 4 |
Magna International
MGA
|
+$579K |
| 5 |
D.R. Horton
DHI
|
+$492K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$2.3M |
| 2 |
PepsiCo
PEP
|
+$1.5M |
| 3 |
Procter & Gamble
PG
|
+$1.48M |
| 4 |
Microsoft
MSFT
|
+$993K |
| 5 |
Apple
AAPL
|
+$591K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.56% |
| 2 | Technology | 13.45% |
| 3 | Industrials | 11.72% |
| 4 | Consumer Staples | 10.18% |
| 5 | Consumer Discretionary | 8.17% |
Similar funds
SCV
TFP
CWM
MG
HWMG
AI
LSWM
IMA
Boston Research & Management's Q1 2022 Portfolio in Review
As of Q1 2022, Boston Research & Management held 117 positions worth $344M, down 5.9% from $366M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Boston Research & Management's Q1 2022 filing shows 5 new, 25 increased, 42 reduced and 6 closed positions. Its largest new stake was Invesco QQQ Trust: 1,170 shares worth $424K. The largest sale was Accenture, an estimated $2.3M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
- Boston Research & Management's largest Q1 2022 buy was Invesco QQQ Trust: 1,170 shares worth $424K.
- Boston Research & Management added most to JPMorgan Chase in Q1 2022, an estimated $1.19M increase.
- Boston Research & Management's biggest Q1 2022 reduction was Accenture, cutting an estimated $2.3M.
- Boston Research & Management fully exited AT&T in Q1 2022, selling an estimated $344K.
- Boston Research & Management's ten largest holdings make up 28% of its $344M portfolio in Q1 2022.
- Boston Research & Management opened 5 new positions and closed 6 in Q1 2022.
- Boston Research & Management's portfolio value fell 5.9% quarter-over-quarter to $344M.
Based on Boston Research & Management's 13F filing for Q1 2022, filed 12 May 2022.